Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-10-30 OCONNELL HOWARD V Director Grant or award · Stock Option (right to buy) +4,000 4,000
2014-10-30 LUCAS ROGER C Director Grant or award +1,000 3,456
2014-10-30 LUCAS ROGER C Director Grant or award · Stock Optoin (right to buy) +4,000 4,000
2014-10-30 BAUMGARTNER ROBERT V Director Grant or award +1,000 5,000
2014-10-30 BAUMGARTNER ROBERT V Director Grant or award · Stock Option (right to buy) +4,000 4,000
2014-09-09 Dinarello Charles A Director Exercise or conversion +5,000 $54.91 $275K 6,000
2014-09-09 Dinarello Charles A Director Exercise or conversion · Stock Options −5,000 1,500
2014-08-14 HOLBROOK KAREN A Director Exercise or conversion +5,000 $57.06 $285K 6,000
2014-08-14 HOLBROOK KAREN A Director Sale −5,000 $95.54 $478K 1,000
2014-08-14 HOLBROOK KAREN A Director Exercise or conversion · Stock Option −5,000 0
2014-08-12 VERONNEAU MARCEL SVP - Clinical Controls Grant or award · Stock Option (Right to Buy) +15,000 15,000
2014-08-12 REAGAN KEVIN J Senior VP - Biotech Grant or award · Stock Option (Right to Buy) +15,000 15,000
2014-08-12 Kummeth Charles R. Chief Executive Officer Grant or award +11,129 43,984
2014-08-12 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +80,460 80,460
2014-08-12 Hippel James Chief Financial Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2014-08-12 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Option (Right to Buy) +15,000 15,000
2014-08-12 EANSOR N DAVID SVP - Novus Biologicals Grant or award · Stock Option (Right to Buy) +15,000 15,000
2014-08-12 Bazan J. Fernando Chief Technical Officer Grant or award · Stock Option (Right to Buy) +15,000 15,000
2014-08-04 Furlow Brenda S. SVP - General Counsel Grant or award +2,500 2,500
2014-07-02 EANSOR N DAVID SVP - Novus Biologicals Grant or award · Restricted Stock Units +5,000 5,000

Page 69 of 75 · 1,487 trades